Search results
Results from the WOW.Com Content Network
Bharat Biotech has its manufacturing facility situated at Genome Valley, Hyderabad, India. [5] As of July 2020, the company has over 700 employees [6] and has a presence worldwide. [5] The company has been responsible for developing an eco-friendly recombinant [7] and a naturally attenuated strain derived Rotavirus vaccine called ROTAVAC.
A vial of Covaxin used at a private hospital in Bengaluru, India. On 6 December 2020, Bharat Biotech applied to the Drugs Controller General of India (DCGI), seeking emergency use authorisation. [60] It was the third firm after Serum Institute of India and Pfizer to apply under such provision. [61]
The product is in line with the recommendations of the WHO. The product is produced with technology transfer from Nutriset through the Department of Biotechnology, Ministry of Science and Technology, Government of India. The Nutriset product has been tested in Indian fields and clinical trials have evaluated the efficacy of zinc supplementation ...
Cambridge, MA, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Alopexx, Inc., a clinical-stage biotechnology company focused on developing novel, broad-spectrum immune-mediated therapeutics for the prevention and treatment of bacterial, fungal, and parasitic infections, today announced a collaboration with Bharat Biotech for the co-development and commercialization of Alopexx’s proprietary broad-spectrum ...
India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a year amid an expanding ...
Genome Valley was commissioned by the then combined Government Andhra Pradesh in 1999 as S. P. Biotech Park in a public-private partnership with Bharat Biotech International, and its founder Krishna Ella, alongside private infrastructure companies such as Shapoorji Pallonji Group and ICICI Bank. [7]
Bharat Biotech is the first in the world to find a vaccine for the Zika virus. [8] [9] Bharat Biotech has delivered over 4 billion vaccines in 123 countries. [4] The vaccine against COVID-19 developed by Bharat Biotech, named Covaxin, was endorsed by the Indian government with an active push by theā Indian Prime Minister Narendra Modi. [10]
iNCOVACC (codenamed BBV154) [1] is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, [2] [3] American company Precision Virologics [4] [5] and the Washington University School of Medicine in St Louis, Missouri, United States.